Literature DB >> 28218461

Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins.

C Warren Olanow1,2, Jeffrey H Kordower3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28218461     DOI: 10.1002/mds.26935

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  8 in total

1.  Using global team science to identify genetic parkinson's disease worldwide.

Authors:  Eva-Juliane Vollstedt; Meike Kasten; Christine Klein
Journal:  Ann Neurol       Date:  2019-06-26       Impact factor: 10.422

Review 2.  Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.

Authors:  Delphine Charvin; Rossella Medori; Robert A Hauser; Olivier Rascol
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

Review 3.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

4.  Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.

Authors:  Qian Ren; Min Ma; Jun Yang; Risa Nonaka; Akihiro Yamaguchi; Kei-Ichi Ishikawa; Kenta Kobayashi; Shigeo Murayama; Sung Hee Hwang; Shinji Saiki; Wado Akamatsu; Nobutaka Hattori; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

5.  A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.

Authors:  Lasse Pihlstrøm; Cornelis Blauwendraat; Chiara Cappelletti; Victoria Berge-Seidl; Margrete Langmyhr; Sandra Pilar Henriksen; Wilma D J van de Berg; J Raphael Gibbs; Mark R Cookson; Andrew B Singleton; Mike A Nalls; Mathias Toft
Journal:  Ann Neurol       Date:  2018-08-26       Impact factor: 10.422

Review 6.  Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.

Authors:  Jianhua Zhang; Matilda Lillian Culp; Jason G Craver; Victor Darley-Usmar
Journal:  J Neurochem       Date:  2018-02-14       Impact factor: 5.372

Review 7.  Emerging therapies in Parkinson disease - repurposed drugs and new approaches.

Authors:  Ahmad Elkouzi; Vinata Vedam-Mai; Robert S Eisinger; Michael S Okun
Journal:  Nat Rev Neurol       Date:  2019-04       Impact factor: 42.937

8.  Cooperative inhibition of SNARE-mediated vesicle fusion by α-synuclein monomers and oligomers.

Authors:  Gyeongji Yoo; Sanghun Yeou; Jung Bae Son; Yeon-Kyun Shin; Nam Ki Lee
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.